CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
This project focuses on improving the production of antibody-drug conjugates (ADCs) for cancer treatment by developing a novel chemical method called Multicomponent Synthetic Conjugation (MuSyC). This approach aims to enhance the efficiency and safety of ADCs, enabling the creation of next-generation therapies with a b…
Cancer remains one of the leading causes of death worldwide and in Europe in particular.
In the continuous fight against this disease, the recent emergence of antibody-drug conjugates (ADCs) has unveiled tremendous hope for the patients.
Composed of an antibody that binds cancer cells selectively, ADCs are capable of delivering a cytotoxic drug into tumors selectively, resulting in targeted cell death.
Even though a dozen ADCs has already been marketed, they are still extremely expensive and tim…
CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE CNRS
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
Guests see up to 5 keywords.
